Clinical Trial Update: The Application of Intralesional 5-fluorouracil for the Management of Hypertrophic Facial Scars in the Periocular Region Resulting From Trauma and Surgical Procedures in Individuals Aged Over 18 Years [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating intralesional 5-fluorouracil for hypertrophic facial scars in the periocular region, with recruitment ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Facial Scarring
• Hypertrophic Scar

Drugs mentioned

• 5-Fluorouracil (5-FU)

Snippet

Sponsor: Instituto de Oftalmología Fundación Conde de Valenciana | Conditions: Facial Scarring | Phase 4 | Status: RECRUITING